Value Aligned Research Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Onto Innovation
ONTO
|
+$34.8M |
| 2 |
Marvell Technology
MRVL
|
+$22.8M |
| 3 |
Vertiv
VRT
|
+$20.4M |
| 4 |
Camtek
CAMT
|
+$15.9M |
| 5 |
Astera Labs
ALAB
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$80.4M |
| 2 |
Cadence Design Systems
CDNS
|
+$40.2M |
| 3 |
Intel
INTC
|
+$35.8M |
| 4 |
Synopsys
SNPS
|
+$28M |
| 5 |
KLA
KLAC
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 91.32% |
| 2 | Industrials | 8.57% |
| 3 | Communication Services | 0.07% |
Similar funds
Value Aligned Research Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Value Aligned Research Advisors held 36 positions worth $457M, down 9.9% from $507M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Value Aligned Research Advisors withdrew a net $78.3M in Q2 2024, closing 5 positions and reducing 3 holdings. Its most notable exit was Advanced Micro Devices, an estimated $80.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 91% of assets, down from 96% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Value Aligned Research Advisors opened a new position in Celestica worth $3.98M.
- Value Aligned Research Advisors's largest Q2 2024 buy was Celestica: 69,356 shares worth $3.98M.
- Value Aligned Research Advisors added most to Onto Innovation in Q2 2024, an estimated $34.8M increase.
- Value Aligned Research Advisors's biggest Q2 2024 reduction was KLA, cutting an estimated $25.2M.
- Value Aligned Research Advisors fully exited Advanced Micro Devices in Q2 2024, selling an estimated $80.4M.
- Value Aligned Research Advisors's ten largest holdings make up 87% of its $457M portfolio in Q2 2024.
- Value Aligned Research Advisors opened 17 new positions and closed 5 in Q2 2024.
- Value Aligned Research Advisors's portfolio value fell 9.9% quarter-over-quarter to $457M.
Based on Value Aligned Research Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.